Dr. Jhanelle Gray takes the reins as chair of the SWOG Lung Cancer Committee. Keep reading for more about this and other moves in thoracic oncology. Read more
TTLC goes virtual. Positive results reported for pembrolizumab. GO2 Foundation names Chief of Healthcare Delivery. Read more
Longtime member Karen Kelly, MD, is set to become the new chief executive officer of the International Association for the Study of Lung Cancer. This March, Dr. Kelly, an internationally […] Read more
Ticiana Leal, MD, has moved to Emory University School of Medicine as associate professor and director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology. […] Read more
Prof. Fabrice Barlesi has been appointed as chief executive officer of Gustave Roussy for a term of 5 years. Prof. Barlesi has been medical director and clinical research director there […] Read more
David R. Gandara, MD, has been appointed chief medical officer (CMO) of the International Society for liquid biopsy (ISLB), an international nonprofit organization dedicated to advancing the field of liquid […] Read more
Narjust Duma, MD, has been named associate director of the Cancer Care Equity Program and assistant professor of medicine at Dana-Farber Cancer Institute/Harvard Medical School. She will develop strategies to […] Read more
Peter Bach, MD, is the new chief medical officer at Delfi Diagnostics, a developer of blood tests for early detection of multiple types of cancer. Dr. Bach leaves Memorial Sloan […] Read more
Joshua Bauml, MD, has moved to The Janssen Pharmaceutical Companies of Johnson & Johnson from the University of Pennsylvania. Dr. Bauml was with the University of Pennsylvania for a decade—2 […] Read more
Jean-Charles Soria, MD, PhD, joined Amgen in early August 2021 as senior vice president of the oncology therapeutic sector. Prof. Soria, previously served as senior vice president of Research & […] Read more